Traditional angle closure glaucoma management, including LPI, is being challenged due to limited evidence of efficacy in preventing visual field loss. The ZAP study suggests LPI's limited prophylactic ...
The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...
Men with benign prostatic hyperplasia (BPH) who took alpha-blockers to manage the condition were roughly 50% more likely to develop acute angle-closure glaucoma than were those who did not use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results